drugset / Trial / NCT01214122
A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of Warfarin
Open-labelBasic science
Summary
The primary purpose of this study is to determine whether the treatment with AZD9668 will affect the metabolism and effect of Warfarin.
Timeline
- Start
- 2010-11
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alvelestat | Small molecule | 60 mg | Oral |
| Subject | Warfarin | Small molecule | 25 mg | Oral |
Indications
No indication recorded.